← Leaderboards
Ronald Levy
Columbia Univ New York Morningside
$18,113,005
Attributed
$18,416,636
Total exposure
33
Grants
20
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$19,778,273 · 34
By mechanism
R01$8,711,514 · 3
R35$2,826,468 · 1
U54$2,765,801 · 2
T90$1,392,834 · 1
P20$1,361,637 · 2
P50$1,040,024 · 1
Top collaborators
- Jean S Baum2 shared
Others in their field
Top investigators on “Proteins”
- David Heimbrook · Leidos Biomedical Research, Inc.$354,061,551
- Randall J Bateman · Washington University$187,292,085
- Paul S. Aisen · Cognition Therapeutics, Inc.$175,382,342
- Reisa A. Sperling · Banner Health$145,046,481
- Barton F Haynes · Duke University$136,029,850
- Joseph L Goldstein · University Of Texas Sw Med Ctr/Dallas$102,433,280
Research focus
ProteinsStructural BiologyThermodynamicsBaseStructureBiophysicsSamplingMolecularSolventsSimulationFree EnergyMolecular DynamicsCollaborationsComputer SimulationInsightKineticsHiv-1LigandsGrantComplexInhibitor/AntagonistProtein StructureMolecular ConformationDrug Resistance
Grant awards (88)
Mechanisms of HIV fitness and drug resistance inferred from high-resolution molecular dynamics and sequence co-variation models$661,831
R01 · FY2025 · AI · contact PI
Mapping Fitness & Free Energy Landscapes of Proteins$391,793
R35 · FY2025 · GM · contact PI
Mechanisms of HIV fitness and drug resistance inferred from high-resolution molecular dynamics and sequence co-variation models$661,831
R01 · FY2024 · AI · contact PI
Mapping Fitness & Free Energy Landscapes of Proteins$391,793
R35 · FY2024 · GM · contact PI
Mechanisms of HIV fitness and drug resistance inferred from high-resolution molecular dynamics and sequence co-variation models$691,081
R01 · FY2023 · AI · contact PI
Mapping Fitness and Free Energy Landscapes of Proteins$371,303
R35 · FY2023 · GM · contact PI
Mapping Fitness and Free Energy Landscapes of Proteins$371,303
R35 · FY2022 · GM · contact PI
Mapping Fitness and Free Energy Landscapes of Proteins$214,578
R35 · FY2022 · GM · contact PI
Evolution of antiviral resistance mutations and their biological and biophysical implications$1,175,609
U54 · FY2021 · AI · contact PI
Mapping Fitness and Free Energy Landscapes of Proteins$371,303
R35 · FY2021 · GM · contact PI
Evolution of antiviral resistance mutations and their biological and biophysical implications$647,079
U54 · FY2020 · AI · contact PI
Mapping Fitness and Free Energy Landscapes of Proteins$371,303
R35 · FY2020 · GM · contact PI
Mapping Fitness and Free Energy Landscapes of Proteins$343,092
R35 · FY2019 · GM · contact PI
Evolution of antiviral resistance mutations and their biological and biophysical implications$278,836
U54 · FY2019 · AI · contact PI
Computer Simulations of Protein Structure and Dynamics$334,776
R01 · FY2018 · GM · contact PI
Evolution of antiviral resistance mutations and their biological and biophysical implications$323,768
U54 · FY2018 · GM · contact PI
Evolution of antiviral resistance mutations and their biological and biophysical implications$340,509
U54 · FY2017 · GM · contact PI
Computer Simulations of Protein Structure and Dynamics$334,776
R01 · FY2017 · GM · contact PI
Computer Simulations of Protein Structure and Dynamics$334,776
R01 · FY2016 · GM · contact PI
Project 8$212,660
P50 · FY2016 · GM · contact PI
Computer Cluster for Computational Biology and Biophysics$442,269
S10 · FY2015 · OD · contact PI
Computer Simulations of Protein Structure and Dynamics$334,776
R01 · FY2015 · GM · contact PI
Project 8$197,024
P50 · FY2015 · GM · contact PI
Computer Simulations of Protein Structure and Dynamics$312,000
R01 · FY2014 · GM · contact PI
Project 8$212,935
P50 · FY2014 · GM · contact PI
Computer Simulations of Protein Structure and Dynamics$50,000
R01 · FY2014 · GM · contact PI
Computer Simulations of Protein Structure and Dynamics$255,560
R01 · FY2013 · GM · contact PI
Project 8$207,878
P50 · FY2013 · GM · contact PI
Computer Simulations of Protein Structure and Dynamics$41,634
R01 · FY2013 · GM · contact PI
Computer Simulations of Protein Structure and Dynamics$308,928
R01 · FY2012 · GM · contact PI
Project 8$209,527
P50 · FY2012 · GM · contact PI
Computer Simulations of Protein Structure and Dynamics$307,288
R01 · FY2011 · GM · contact PI
Computer Simulations of Protein Structure and Dynamics$304,361
R01 · FY2010 · GM · contact PI
Experiments & Computations to Find Aggregation-Prone Ensembles of Alpha-Synuclein$300,710
R01 · FY2010 · GM
Computer Simulations of Protein Structure and Dynamics$307,435
R01 · FY2009 · GM · contact PI
Experiments & Computations to Find Aggregation-Prone Ensembles of Alpha-Synuclein$306,553
R01 · FY2009 · GM
Computer Simulations of Protein Structure and Dynamics$145,261
R01 · FY2009 · GM · contact PI
Computer Simulations of Protein Structure and Dynamics$307,435
R01 · FY2008 · GM · contact PI
Training for Integrative Proteomics Technologies(RMI)$288,854
T90 · FY2008 · DK · contact PI
Training for Integrative Proteomics Technologies(RMI)$129,723
R90 · FY2008 · DK · contact PI
CLINICAL TRIAL: ATLR 9 AGONIST, COMBINED WITH LOCAL RADIATION IN RECURRENT LOW-G$9,784
M01 · FY2008 · RR · contact PI
CLINICAL TRIAL: KLH WITH GM-CSF, IN PATIENTS WITH FOLLICULAR NON-HODGKIN'S LYMPH$455
M01 · FY2008 · RR · contact PI
Computer Simulations of Protein Structure and Dynamics$307,435
R01 · FY2007 · GM · contact PI
Computer Cluster for Computational and Structural Biology$290,913
S10 · FY2007 · RR · contact PI
Training for Integrative Proteomics Technologies(RMI)$277,466
T90 · FY2007 · DK · contact PI
Training for Integrative Proteomics Technologies(RMI)$121,062
R90 · FY2007 · DK · contact PI
ATLR 9 AGONIST, COMBINED WITH LOCAL RADIATION IN RECURRENT LOW-GRADE LYMPHOMAS$44,471
M01 · FY2007 · RR · contact PI
VACCINE THERAPY FOR MULTIPLE MYELOMA ALLOGENEIC DENDRITIC CELLS$9,362
M01 · FY2007 · RR · contact PI
KLH WITH GM-CSF, IN PATIENTS WITH FOLLICULAR NON-HODGKIN'S LYMPHOMA$6,437
M01 · FY2007 · RR · contact PI
PATIENTS WITH STABLE OR PROGRESSIVE GRADE 1 OR 2 FOLLICULAR B-CELL LYMPHOMAS$3,511
M01 · FY2007 · RR · contact PI
Computer Simulations of Protein Structure and Dynamics$302,072
R01 · FY2006 · GM · contact PI
Training for Integrative Proteomics Technologies$228,286
T90 · FY2006 · DK · contact PI
Training for Integrative Proteomics Technologies$122,776
R90 · FY2006 · DK · contact PI
Training for Integrative Proteomics Technologies$37,334
T90 · FY2006 · DK · contact PI
IMMUNOTHERAPY IN PATIENTS WITH FOLLICULAR NON-HODGKIN'S LYMPHOMA$20,459
M01 · FY2006 · RR · contact PI
PROTOCOL G2002-09: A PHASE II STUDY TO EVALUATE THE SAFETY AND EFFICACY$12,453
M01 · FY2006 · RR · contact PI
ATLR 9 AGONIST, COMBINED WITH LOCAL RADIATION IN RECURRENT LOW-GRADE LYMPHOMAS$5,337
M01 · FY2006 · RR · contact PI
VACCINE THERAPY FOR MULTIPLE MYELOMA UTILIZING ALLOGENEIC DENDRITIC CELLS$2,224
M01 · FY2006 · RR · contact PI
Computer Simulations of Protein Structure and Dynamics$309,342
R01 · FY2005 · GM
Training for Integrative Proteomics Technologies(RMI)$276,667
T90 · FY2005 · DK
Training for Integrative Proteomics Technologies(RMI)$116,245
R90 · FY2005 · DK
IMMUNOTHERAPY IN PATIENTS WITH FOLLICULAR NON-HODGKIN'S LYMPHOMA$20,715
M01 · FY2005 · RR
IMMUNOTHERAPY IN PATIENTS WITH FOLLICULAR NON-HODGKIN'S LYMPHOMA$3,341
M01 · FY2005 · RR
INTRATUMORAL INJECTION, COMBINED WITH LOCAL RADIATION IN LOW-GRADE LYMPHOMAS$2,005
M01 · FY2005 · RR
Computer Simulations of Protein Structure and Dynamics$309,342
R01 · FY2004 · GM
Training for Integrative Proteomics Technologies (RMI)$284,227
T90 · FY2004 · DK
Training for Integrative Proteomics Technologies (RMI)$120,025
R90 · FY2004 · DK
A Phase III Trial to Evaluate the Safety and Efficacy$20,150
M01 · FY2004 · RR
Phase I Dose Ranging, Safety &Immunogenicity of Vaccine$593
M01 · FY2004 · RR
Rituxan Anti-CD20 Antibody in Patients w/ Follicular NHL$593
M01 · FY2004 · RR
An Open-labeled, Phase 2 Study of Rituximab$296
M01 · FY2004 · RR
Phase II Trial to Evaluate the Efficacy of Immunotherapy$296
M01 · FY2004 · RR
Biocomputing: Regulation of Gene Expression$466,202
P20 · FY2003 · GM
Computer Simulations of Protein Structure and Dynamics$309,342
R01 · FY2003 · GM
Biocomputing: Regulation of Gene Expression$453,759
P20 · FY2002 · GM
COMPUTER SIMULATIONS OF PROTEIN STRUCTURE AND DYNAMICS$295,577
R01 · FY2002 · GM
4 MONTH BIOMED GRANT LETTER WAS SENT TO D DEERFIELD$0
P41 · FY2002 · RR
4 MONTH BIOMED GRANT LETTER WAS SENT TO D DEERFIELD$0
P41 · FY2002 · RR
MODELS OF SUPRAMOLECULAR TRANSCRIPTIONAL ASSEMBLIES$0
P20 · FY2002 · GM
Biocomputing: Regulation of Gene Expression$441,676
P20 · FY2001 · GM
COMPUTER SIMULATIONS OF PROTEIN STRUCTURE AND DYNAMICS$290,960
R01 · FY2001 · GM
4 MONTH BIOMED GRANT LETTER WAS SENT TO D DEERFIELD$0
P41 · FY2001 · RR
MODELS OF SUPRAMOLECULAR TRANSCRIPTIONAL ASSEMBLIES$0
P20 · FY2001 · GM
COMPUTER SIMULATIONS OF PROTEIN STRUCTURE AND DYNAMICS$286,432
R01 · FY2000 · GM
ELECTROSTATIC EFFECTS ON PROTEIN UNFOLDING$43,625
P41 · FY2000 · RR
PKA SHIFTS IN PROTEINS$43,625
P41 · FY2000 · RR
THERMODYNAMICS OF SMALL ORGANIC MOLECULES IN AQUEOUS SOLUTION$43,625
P41 · FY2000 · RR
LARGE SCALE SIMULATIONS OF PROTEINS IN AQUEOUS SOLUTION$43,625
P41 · FY2000 · RR